文献速递先天性心脏病外科

法洛四联症合并主要主肺动脉侧支血管的婴幼儿完全单源化与修复后的肺动脉再干预

Pulmonary reinterventions after complete unifocalization and repair in infants and young children with tetralogy of Fallot with major aortopulmonary collaterals.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-12-13

本中心对法洛四联症(TOF)合并主要主肺动脉侧支血管(MAPCAs)采取婴儿期单源化、重建肺动脉(PA)循环并完全心内修复的策略。回顾272例2岁以下完成修复的患儿,中位随访3.6年,134例接受肺动脉循环再干预,5年免于导管替换或经导管肺动脉瓣替换率为70±3%,免于任何PA再干预率为64±3%。

要点

  • 完全修复后5年免于导管替换或经导管肺动脉瓣替换率为70±3%。
  • 完全修复后5年免于任何PA再干预率为64±3%,第一年发生率最高。
  • 较低的修复后右心室与主动脉压力比和较大的初始导管尺寸与更长的免于PA再干预相关。

核心结论

  • 本中心对TOF合并MAPCAs的婴儿期完全修复策略下,多数患者可获得随访数据,约三分之二患者免于PA再干预。
  • 该队列导管再干预的时间过程和危险因素与既往报道的因其他畸形在幼年期接受右心室-肺动脉(RV-PA)导管的患者相似。
  • 相对于TOF合并MAPCAs基线肺动脉血管解剖的严重程度,按本中心方法修复后重建PA的再干预不常见,重大再干预罕见。
  • PA再干预仍是整体管理策略中的重要方面。

研究设计与样本

  • 回顾性队列研究,纳入本中心2岁以内完成TOF合并MAPCAs完全修复的患者272例,修复方式为单期手术或分期手术后完成。
  • 采用Cox回归和Kaplan-Meier分析评估修复后免于导管或PA干预的情况。

主要发现

  • 队列包括272例患者,早期死亡6例,完全修复后中位随访3.6年。
  • 134例患者接受肺动脉循环再干预,其中导管干预101例、分支PA干预101例、残余MAPCAs关闭9例。
  • 首次导管再干预中,外科导管替换77例、经导管Melody瓣肺动脉瓣替换14例、血管成形术或裸金属支架置入10例。
  • 外科PA再干预46例,经导管再干预75例(两者均行20例);多数PA再干预涉及单侧肺,多数经导管再干预涉及单支血管。
  • 5年免于导管替换或经导管肺动脉瓣替换率为70±3%,初始导管尺寸较小的患者更短;5年免于任何PA再干预率为64±3%,第一年发生率最高。

临床怎么用

  • 本研究中心的做法是婴儿期单源化并 augmentation 重建肺动脉循环,通常以单期手术完成完全心内修复。
  • 作者指出PA再干预是整体管理策略中的重要方面。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our institutional approach to tetralogy of Fallot (TOF) with major aortopulmonary collaterals (MAPCAs) emphasizes unifocalization and augmentation of the reconstructed pulmonary arterial (PA) circulation and complete intracardiac repair in infancy, usually in a single procedure. This approach yields a high rate of complete repair with excellent survival and low right ventricular (RV) pressure. However, little is known about remodeling of the unifocalized and reconstructed pulmonary circulation or about reinterventions on the reconstructed PAs or the RV outflow tract conduit. METHODS: We reviewed patients who underwent complete repair of TOF with MAPCAs at our center at <2 years of age, either as a single-stage procedure or after previous procedures. Outcomes included freedom from conduit or PA intervention after repair, which were assessed by Cox regression and Kaplan-Meier analysis. RESULTS: The study cohort included 272 patients. There were 6 early deaths and a median of follow-up of 3.6 years after complete repair. Reinterventions on the pulmonary circulation were performed in 134 patients, including conduit interventions in 101 patients, branch PA interventions in 101, and closure of residual MAPCAs in 9. The first conduit reintervention consisted of surgical conduit replacement in 77 patients, transcatheter pulmonary valve replacement with a Melody valve in 14, and angioplasty or bare metal stenting in 10. Surgical PA reinterventions were performed in 46 patients and transcatheter reinterventions in 75 (both in 20). Most PA reinterventions involved a single lung, and most transcatheter reinterventions a single vessel. Freedom from conduit replacement or transcatheter pulmonary valve replacement was 70 ± 3% at 5 years and was shorter in patients with smaller initial conduit size. Freedom from any PA reintervention was 64 ± 3% at 5 years, with the greatest rate during the first year. On multivariable analysis, factors associated with longer freedom from any PA reintervention included lower postrepair RV:aortic pressure ratio and larger original conduit size. CONCLUSIONS: We were able to obtain follow-up data for the majority of patients, which demonstrated freedom from PA reintervention for two thirds of patients. The time course of and risk factors for conduit reintervention in this cohort appeared similar to previously reported findings in patients who received RV-PA conduits in early childhood for other anomalies. Relative to the severity of baseline pulmonary vascular anatomy in TOF with MAPCAs, reinterventions on the reconstructed PAs were uncommon after repair according to our approach, and major reinterventions were rare. Nevertheless, PA reinterventions are an important aspect of the overall management strategy.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bauser-Heaton H, Borquez A, Asija R, et al. Pulmonary reinterventions after complete unifocalization and repair in infants and young children with tetralogy of Fallot with major aortopulmonary collaterals. J Thorac Cardiovasc Surg. 2017. PMID: 29352588. doi:10.1016/j.jtcvs.2017.11.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。